Scientists scan brains to see how MS drug fights inflammation
NCT ID NCT04230174
Summary
This study used advanced brain scans to see if the approved MS drug ocrelizumab reduces inflammation in the brain. Researchers scanned 22 patients with multiple sclerosis before and after about a year of standard ocrelizumab treatment. The goal was to understand how the drug works in the brain by measuring changes in inflammation and brain tissue health.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Massachusetts General Hospital
Charlestown, Massachusetts, 02129, United States
Conditions
Explore the condition pages connected to this study.